Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Rev Mal Respir ; 39(1): 62-66, 2022 Jan.
Article in French | MEDLINE | ID: mdl-34969538

ABSTRACT

INTRODUCTION: The third-generation tyrosine kinase inhibitor (TKI) osimertinib is recommended as a first-line treatment in advanced non-small cell lung cancer harboring an activating mutation of Epidermal Growth Factor Receptor (EGFR). Adverse pulmonary events related to osimertinib exposure have been reported, primarily in Japanese patients. They rarely occur in the Caucasian population. OBSERVATION: Herein we report two clinical cases of osimertinib-induced lung toxicities in patients diagnosed with advanced lung adenocarcinoma harboring an EGFR mutation. In the first case, interstitial pneumonia was asymptomatic and evolved favorably after osimertinib discontinuation. The second patient presented a more extensive form of lung injuries and despite systemic corticosteroid therapy, the evolution was fatal. CONCLUSION: Osimertinib-related lung toxicities remain exceptional. While most forms are mild, consideration of TKI treatment discontinuation may be necessitated. Introduction of another TKI or rechallenge with osimertinib might be considered along with corticosteroid therapy if necessary. Diffuse alveolar damage is a pejorative prognostic factor.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Acrylamides , Aniline Compounds , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/genetics , Humans , Lung , Lung Neoplasms/drug therapy , Mutation , Protein Kinase Inhibitors/adverse effects
2.
Eur J Clin Microbiol Infect Dis ; 40(11): 2437-2442, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33907935

ABSTRACT

We conducted an observational retrospective study of all adults hospitalized for documented varicella-zoster virus (VZV) meningitis or encephalitis during years 2000-2015 in one referral centre. Thirty-six patients (21 males, 15 females) were included, with meningitis (n = 21), or meningoencephalitis (n = 15). Median age was 51 years [interquartile range, 35-76], and 6 patients (17%) were immunocompromised. Aciclovir was started in 32 patients (89%), with a median dose of 11 mg/kg/8 h [10-15]. No patient died, but 12 (33%) had neurological sequelae at discharge. Age was the only variable associated with adverse outcome (OR 1.98 [1.17-3.35] per 10-year increment, P = 0.011).


Subject(s)
Central Nervous System Infections/virology , Herpes Zoster/virology , Herpesvirus 3, Human/physiology , Acyclovir/therapeutic use , Adult , Aged , Antiviral Agents/therapeutic use , Central Nervous System Infections/drug therapy , Central Nervous System Infections/immunology , Female , Herpes Zoster/drug therapy , Herpes Zoster/immunology , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/isolation & purification , Humans , Immunocompromised Host , Male , Middle Aged , Retrospective Studies
3.
J Antimicrob Chemother ; 76(5): 1242-1249, 2021 04 13.
Article in English | MEDLINE | ID: mdl-33569597

ABSTRACT

OBJECTIVES: To describe the impact of extracorporeal membrane oxygenation (ECMO) devices on piperacillin exposure in ICU patients. METHODS: This observational, prospective, multicentre, case-control study was performed in the ICUs of two tertiary care hospitals in France. ECMO patients with sepsis treated with piperacillin/tazobactam were enrolled. Control patients were matched according to SOFA score and creatinine clearance. The pharmacokinetics of piperacillin were described based on a population pharmacokinetic model, calculating the proportion of time the piperacillin plasma concentration was above 64 mg/L (i.e. 4× MIC breakpoint for Pseudomonas aeruginosa). RESULTS: Forty-two patients were included. Median (IQR) age was 60 years (49-66), SOFA score was 11 (9-14) and creatinine clearance was 47 mL/min (5-95). There was no significant difference in the proportion of time piperacillin concentrations were ≥64 mg/L in patients treated with ECMO and controls during the first administration (P = 0.184) or at steady state (P = 0.309). Following the first administration, 36/42 (86%) patients had trough piperacillin concentrations <64 mg/L. Trough concentrations at steady state were similar in patients with ECMO and controls (P = 0.535). Creatinine clearance ≥40 mL/min was independently associated with piperacillin trough concentration <64 mg/L at steady state [OR = 4.3 (95% CI 1.1-17.7), P = 0.043], while ECMO support was not [OR = 0.5 (95% CI 0.1-2.1), P = 0.378]. CONCLUSIONS: ECMO support has no impact on piperacillin exposure. ICU patients with sepsis are frequently underexposed to piperacillin, which suggests that therapeutic drug monitoring should be strongly recommended for severe infections.


Subject(s)
Extracorporeal Membrane Oxygenation , Sepsis , Aged , Anti-Bacterial Agents , Case-Control Studies , France , Humans , Middle Aged , Piperacillin , Prospective Studies , Sepsis/drug therapy
4.
Eur J Clin Microbiol Infect Dis ; 39(4): 629-635, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31773364

ABSTRACT

The optimal timing of cardiac surgery in infective endocarditis (IE) remains debated: Early surgery decreases the risk of embolism, and heart failure, but is associated with an increased rate of positive valve culture. To determine the determinants, and the consequences, of positive valve culture when cardiac surgery is performed during the acute phase of IE, we performed a retrospective study of adult patients who underwent cardiac surgery for definite left-sided IE (Duke Criteria), in two referral centres. During the study period (2002-2016), 148 patients fulfilled inclusion criteria. Median age was 65 years [interquartile range, 53-73], male-to-female ratio was 2.9 (110/38). Cardiac surgery was performed after 14 days [5-26] of appropriate antibiotics. Valve cultures returned positive in 46 cases (31.1%). Factors independently associated with positive valve culture were vegetation size ≥ 10 mm (OR 2.83 [1.16-6.89], P = 0.022) and < 14 days of appropriate antibacterial treatment before surgery (OR 4.68 [2.04-10.7], P < 0.001). Positive valve culture was associated with increased risk of postoperative acute respiratory distress syndrome (37.0% vs. 15.7%, P = 0.008) but was associated neither with an increased risk of postoperative relapse nor with the need for additional cardiac surgery. Duration of appropriate antibacterial treatment and vegetation size are independently predictive of positive valve culture in patients operated during the acute phase of IE. Positive valve culture is associated with increased risk of postoperative acute respiratory distress syndrome.


Subject(s)
Cardiac Surgical Procedures/standards , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/surgery , Heart Valves/microbiology , Acute Disease , Aged , Anti-Bacterial Agents/therapeutic use , Bacteria/isolation & purification , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Colony Count, Microbial , Endocarditis, Bacterial/drug therapy , Female , Humans , Male , Middle Aged , Respiratory Distress Syndrome/etiology , Retrospective Studies , Risk Factors
5.
Rev Mal Respir ; 32(4): 344-57, 2015 Apr.
Article in French | MEDLINE | ID: mdl-25595878

ABSTRACT

Parapneumonic pleural effusions represent the main cause of pleural infections. Their incidence is constantly increasing. Although by definition they are considered to be a "parapneumonic" phenomenon, the microbial epidemiology of these effusions differs from pneumonia with a higher prevalence of anaerobic bacteria. The first thoracentesis is the most important diagnostic stage because it allows for a distinction between complicated and non-complicated parapneumonic effusions. Only complicated parapneumonic effusions need to be drained. Therapeutic evacuation modalities include repeated therapeutic thoracentesis, chest tube drainage or thoracic surgery. The choice of the first-line evacuation treatment is still controversial and there are few prospective controlled studies. The effectiveness of fibrinolytic agents is not established except when they are combined with DNase. Antibiotics are mandatory; they should be initiated as quickly as possible and should be active against anaerobic bacteria except for in the context of pneumococcal infections. There are few data on the use of chest physiotherapy, which remains widely used. Mortality is still high and is influenced by underlying comorbidities.


Subject(s)
Pleural Effusion , Disease Management , Drainage/methods , Humans , Pleural Effusion/classification , Pleural Effusion/diagnosis , Pleural Effusion/epidemiology , Pleural Effusion/therapy , Thoracentesis/methods
6.
Infection ; 42(3): 493-502, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24464791

ABSTRACT

PURPOSE: The reduction in acquired infections (AI) due to methicillin-resistant Staphylococcus aureus (MRSA) with the mupirocin/chlorhexidine (M/C) decontamination regimen has not been well studied in intubated patients. We performed post hoc analysis of a prior trial to assess the impact of M/C on MRSA AI and colonization. METHODS: We conducted a multicenter, placebo-controlled, randomized, double-blind study with the primary aim to reduce all-cause AI. The two regimens used [topical polymyxin and tobramycin (P/T), nasal mupirocin with chlorhexidine body wash (M/C), or corresponding placebos for each regimen] were administered according to a 2 × 2 factorial design. Participants were intubated patients in the intensive care units of three French university hospitals. The patients enrolled in the study (n = 515) received either active P/T (n = 130), active M/C (n = 130), both active regimens (n = 129), or placebos only (n = 126) for the period of intubation and an additional 24 h. The incidence and incidence rates (per 1,000 study days) of MRSA AI were assessed. Due to the absence of a statistically significant interaction between the two regimens, analysis was performed at the margins by comparing all patient receiving M/C (n = 259) to all patients not receiving M/C (n = 256), and all patients receiving P/T (n = 259) to all patients not receiving P/T (n = 256). RESULTS: Incidence [odds ratio (OR) 0.39, 95 % confidence interval (CI) (0.16-0.96), P = 0.04] and incidence rates [incidence rate ratio (IRR) 0.41, 95 % CI 0.17-0.97, P = 0.05] of MRSA AI were significantly lower with the use of M/C. We also observed an increase in the incidence (OR 2.50, 95 % CI 1.01-6.15, P = 0.05) and the incidence rate (IRR 2.90, 95 % CI 1.20-8.03, P = 0.03) of MRSA AI with the use of P/T. CONCLUSION: Among our study cohort of intubated patients, the use of M/C significantly reduced MRSA AI.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Chlorhexidine/therapeutic use , Intubation/adverse effects , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Mupirocin/therapeutic use , Staphylococcal Infections/prevention & control , Administration, Topical , Adult , Aged , Aged, 80 and over , Double-Blind Method , Drug Therapy, Combination/methods , Female , France , Hospitals, University , Humans , Incidence , Male , Middle Aged , Placebos/administration & dosage , Polymyxins/therapeutic use , Staphylococcal Infections/microbiology , Tobramycin/therapeutic use , Treatment Outcome , Young Adult
7.
Reanimation ; 23(1): 9-16, 2014.
Article in French | MEDLINE | ID: mdl-32288738

ABSTRACT

Although mechanical ventilation is an essential support in patients admitted to the intensive care unit, clinical and experimental studies have shown that it could be harmful and could induce lung injury. Pulmonary and immune cells can convert mechanical stimuli into biological signals that will lead to inflammation. This sterile inflammation both locally and systemically will cause immunosuppression.

8.
J Clin Microbiol ; 51(10): 3454-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23903544

ABSTRACT

Common presentations of tularemia include pneumonia and ulceroglandular, oropharyngeal, or typhoidal disease. Neuromeningeal involvement is extremely rare. We report a case of a severe rhombencephalitis due to Francisella tularensis. Diagnosis was possible thanks to a very precise interview, and the patient dramatically improved after specific antibiotherapy.


Subject(s)
Encephalitis/diagnosis , Encephalitis/pathology , Francisella tularensis/isolation & purification , Tularemia/diagnosis , Tularemia/pathology , Anti-Bacterial Agents/therapeutic use , Brain/diagnostic imaging , Encephalitis/drug therapy , Encephalitis/microbiology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Radiography , Treatment Outcome , Tularemia/drug therapy , Tularemia/microbiology
9.
Eur J Clin Microbiol Infect Dis ; 32(2): 189-94, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22930407

ABSTRACT

The purpose of this investigation was to characterize the management and prognosis of severe Pneumocystis jirovecii pneumonia (PJP) in human immunodeficiency virus (HIV)-negative patients. An observational cohort study of HIV-negative adults with PJP documented by bronchoalveolar lavage (BAL) through Gomori-Grocott staining or immunofluorescence, admitted to one intensive care unit (ICU) for acute respiratory failure, was undertaken. From 1990 to 2010, 70 patients (24 females, 46 males) were included, with a mean age of 58.6 ± 18.3 years. The mean Simplified Acute Physiology Score (SAPS)-II was 36.9 ± 20.4. Underlying conditions included hematologic malignancies (n = 21), vasculitis (n = 13), and solid tumors (n = 13). Most patients were receiving systemic corticosteroids (n = 63) and cytotoxic drugs (n = 51). Not a single patient received trimethoprim-sulfamethoxazole as PJP prophylaxis. Endotracheal intubation (ETI) was required in 42 patients (60.0 %), including 38 with acute respiratory distress syndrome (ARDS). In-ICU mortality was 52.9 % overall, reaching 80.9 % and 86.8 %, respectively, for patients who required ETI and for patients with ARDS. In the univariate analysis, in-ICU mortality was associated with SAPS-II (p = 0.0131), ARDS (p < 0.0001), shock (p < 0.0001), and herpes simplex virus (HSV) or cytomegalovirus (CMV) on BAL (p = 0.0031). In the multivariate analysis, only ARDS was associated with in-ICU mortality (odds ratio [OR] 23.4 [4.5-121.9], p < 0.0001). PJP in non-HIV patients remains a serious disease with high in-hospital mortality. Pulmonary co-infection with HSV or CMV may contribute to fatal outcome.


Subject(s)
Coinfection/mortality , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/mortality , Herpes Simplex/complications , Herpes Simplex/mortality , Pneumonia, Pneumocystis/complications , Pneumonia, Pneumocystis/mortality , Aged , Bronchoalveolar Lavage Fluid/virology , Cohort Studies , Cytomegalovirus/isolation & purification , Female , Humans , Male , Middle Aged , Retrospective Studies , Simplexvirus/isolation & purification
10.
Rev Pneumol Clin ; 68(5): 295-9, 2012 Oct.
Article in French | MEDLINE | ID: mdl-22749619

ABSTRACT

Intra-alveolar hemorrhage (IAH) could be revealed by acute respiratory failure. The classic association of hemoptysis - anemia - radiological infiltrates is suggestive and has to be confirmed by broncho-alveolar lavage with Golde score. Etiologies included immune and non-immune diseases, with specific treatment for each. We report a case of IAH revealed by acute respiratory distress syndrome and anemia (3 g/dL), related to pulmonary and cerebral vasculitis without renal involvement. The patient was efficiently treated with corticosteroids and cyclophosphamide. This case highlights the critical role of BAL cytological analysis with Golde score, and the need for a rapid and accurate diagnosis in order to guide specific treatment. If histology is needed, renal biopsy even without renal involvement, or surgical lung biopsy is possible.


Subject(s)
Bronchial Diseases/complications , Hemorrhage/complications , Respiratory Distress Syndrome/etiology , Vasculitis/complications , Bronchial Diseases/diagnosis , Bronchial Diseases/diagnostic imaging , Diagnosis, Differential , Female , Hemorrhage/diagnosis , Hemorrhage/diagnostic imaging , Humans , Middle Aged , Pulmonary Alveoli/pathology , Radiography, Thoracic , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/diagnostic imaging , Vasculitis/diagnosis , Vasculitis/diagnostic imaging
11.
Eur J Clin Microbiol Infect Dis ; 31(10): 2713-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22538796

ABSTRACT

The spectrum of community-acquired pneumonia (CAP) due to Chlamydophila psittaci ranges from mild, self-limited CAP, to acute respiratory failure. We performed a retrospective study of 13 consecutive patients with CAP due to C. psittaci and 51 patients with legionellosis admitted in one intensive care unit (ICU) (1993-2011). As compared to patients with legionellosis, patients with psittacosis were younger (median age 48 [38-59] vs. 60 [50-71] years, p = 0.007), less frequently smokers (38 vs. 79 %, p < 0.001), with less chronic disease (15 vs. 57 %, p = 0.02), and longer duration of symptoms before admission (median 6 [5-13] vs. 5 [3-7] days, p = 0.038). They presented with lower Simplified Acute Physiology Score II (median 28 [19-38] vs. 39 [28-46], p = 0.04) and less extensive infiltrates on chest X-rays (median 2 [1-3] vs. 3 [3-4] lobes, p = 0.007). Bird exposure was mentioned in 100 % of psittacosis cases, as compared to 5.9 % of legionellosis cases (p < 0.0001). Extrapulmonary manifestations, biological features, and mortality (15.4 vs. 21.6 %, p = 0.62) were similar in both groups. In conclusion, severe psittacosis shares many features with severe legionellosis, including extrapulmonary manifestations, biological features, and outcome. Psittacosis is an important differential diagnosis for legionellosis, especially in cases of bird exposure, younger age, and more limited disease progression over the initial few days.


Subject(s)
Chlamydophila Infections/diagnosis , Chlamydophila psittaci/isolation & purification , Community-Acquired Infections/microbiology , Intensive Care Units , Legionella pneumophila/isolation & purification , Legionnaires' Disease/diagnosis , Pneumonia, Bacterial/diagnosis , Adult , Aged , Animals , Chlamydophila Infections/microbiology , Chlamydophila psittaci/pathogenicity , Community-Acquired Infections/diagnosis , Disease Progression , Female , Hospitalization/statistics & numerical data , Humans , Legionella pneumophila/pathogenicity , Legionnaires' Disease/microbiology , Male , Middle Aged , Occupational Exposure/adverse effects , Pneumonia, Bacterial/microbiology , Poultry/microbiology , Radiography, Thoracic , Retrospective Studies , Sepsis/microbiology , Severity of Illness Index , Species Specificity , Time Factors
14.
Rev Mal Respir ; 26(3): 257-65, 2009 Mar.
Article in French | MEDLINE | ID: mdl-19367199

ABSTRACT

OBJECTIVE: To compare the one year survival after discharge from ICU of patients with chronic obstructive pulmonary disease (COPD) admitted for acute hypercapnic respiratory failure and who required mechanical ventilation. METHODS: Retrospective cohort study on 130 patients, 52 patients were treated with non-invasive ventilation (NIV) and 78 patients with conventional mechanical ventilation (CMV). RESULTS: In 73 patients the cause for respiratory failure could not be identified. Long-term survival was significantly better following NIV than with CMV (p=0.02 by log-rank testing), but the better prognosis associated with use of NIV was not found in patients with no documented cause for the respiratory failure. After adjusting for male gender, age>65 years, simplified acute physiology score II>35, prior long-term home oxygen therapy, treatment with steroids, FEV1<30% of predicted value, body-mass index<21 kg/m2, albumin level<30 g/L, right ventricular failure, ventilator-associated pneumonia and cause of respiratory failure, NIV remained independently associated with better outcomes (adjusted hazard ratio 0.55; 95% CI 0.31-0.97; p=0.04). CONCLUSIONS: Our results suggest that in COPD patients requiring mechanical ventilation and who survived after an ICU stay, the use of NIV is an independent factor associated with a better long-term survival, especially in those with a documented cause of respiratory failure.


Subject(s)
Pulmonary Disease, Chronic Obstructive/mortality , Pulmonary Disease, Chronic Obstructive/therapy , Respiration, Artificial/methods , Aged , Cohort Studies , Female , France/epidemiology , Humans , Intensive Care Units , Male , Middle Aged , Retrospective Studies
15.
Lung ; 183(4): 283-9, 2005.
Article in English | MEDLINE | ID: mdl-16211464

ABSTRACT

We retrospectively reviewed 34 consecutive patients with serologically confirmed leptospirosis admitted during years 1992-2002. Nine patients (26.5%) had respiratory symptoms on admission including cough (n = 4), shortness of breath (n = 4), cyanosis (n = 2), and hemoptysis (n = 1). Six patients had pulmonary radiographic findings including (1) diffuse, ill-defined, ground-glass density (n = 3); (2) diffuse alveolar opacities (n = 2); and (3) small nodular density (n = 1). Male/female ratio was 8/1 and mean age was 47 years. Seven patients reported their exposure source including hunting (n = 2), fishing (n = 2), fresh water swimming (n = 2), and canoeing (n = 1). All patients had fever (mean = 40.1 degrees C). Other common symptoms were headache (n = 4), vomiting (n = 3), and myalgia (n = 3). Biological abnormalities included elevated liver enzymes (n = 8), proteinuria (n = 7), lymphopenia (n = 6), hematuria (n = 5), renal failure (n = 4), anemia (n = 4), and elevated neutrophil count (n = 4). PaO(2 )was measured for 3 patients while they were breathing room air (32, 55, and 66 mmHg). Suspected diagnosis on admission included leptospirosis (n = 2), bacterial pneumonia (n = 2), intoxication, influenza, viral hepatitis, biliary tract lithiasis, and rapidly progressive glomerulonephritis (one patient each). The first serologic testing for leptospirosis was positive for 5 patients (55%). Serovar was presumptively identified for 7 patients: Australis (n = 3), Grippotyphosa (n = 2), and Icterohaemorrhagiae (n = 2). Seven patients were treated with penicillin; two patients received no antibiotics. All patients were cured. In conclusion, patients with leptospirosis may present predominantly with nonspecific pulmonary symptoms. In these patients, leptospirosis must be suspected when there is a potential exposure to rats, especially in case of high-grade fever, myalgia, hepatitis, and renal abnormalities.


Subject(s)
Leptospirosis/complications , Respiratory Tract Infections/microbiology , Female , Humans , Leptospirosis/diagnosis , Leptospirosis/physiopathology , Male , Middle Aged , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/physiopathology , Retrospective Studies
16.
Clin Microbiol Infect ; 11(1): 76-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15649311

ABSTRACT

Guidelines recommend high doses of beta-lactams for the therapy of endocarditis. This report describes a retrospective study of 15 endocarditis patients (median age 64 years), treated according to guidelines, whose beta-lactam trough plasma concentrations were measured with high-performance liquid chromatography because of tolerance or efficacy concerns. For amoxycillin, the mean level was 86.8 mg/L (range: 30-212 mg/L); five (45%) patients had concentrations > 1000 x MIC. For cloxacillin, the mean level was 47.9 mg/L (range: 16.7-104 mg/L). The consequences of high and unpredicted beta-lactam trough plasma concentrations for a prolonged period have not yet been thoroughly evaluated.


Subject(s)
Amoxicillin/pharmacokinetics , Anti-Bacterial Agents/pharmacokinetics , Cloxacillin/pharmacokinetics , Drug Monitoring/methods , Endocarditis, Bacterial/drug therapy , beta-Lactams/pharmacokinetics , Adult , Aged , Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Chromatography, High Pressure Liquid , Cloxacillin/therapeutic use , Endocarditis, Bacterial/microbiology , Female , Gram-Positive Cocci/drug effects , Humans , Klebsiella oxytoca/drug effects , Male , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , beta-Lactams/therapeutic use
18.
Intensive Care Med ; 28(6): 686-91, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12107671

ABSTRACT

OBJECTIVE: To compare the outcome of patients with severe Legionella pneumonia (LP) according to the presence or absence of prognostic factors currently reported in the literature and delays in initiating fluoroquinolones and macrolides. DESIGN: Retrospective clinical investigation. SETTING: Intensive care unit (ICU) of an university hospital. PATIENTS: Forty-three consecutive cases with no previous treatment with a macrolide or a fluoroquinolone. MEASUREMENTS AND MAIN RESULTS: The 14 (33%) patients who died of LP were compared with the 29 survivors. Thirty-eight patients (88%) received a fluoroquinolone in combination with a macrolide agent, two patients erythromycin alone and three ofloxacin alone. In univariate analysis, SAPS II more than 46 ( p=0.006) and intubation requirement ( p=0.012) were associated with a higher mortality whereas the administration of fluoroquinolones ( p=0.011) or erythromycin ( p=0.044) within 8 h of arrival on the ICU was associated with better survival. By logistic regression analysis, SAPS II score more than 46 [odds ratio (OR) 8.69; 95% confidence interval (CI) 1.15-66.7; p=0.036], duration of symptoms prior to ICU admission longer than 5 days (OR 7.46; 95% CI 1.17-47.6) were independent risk factors for death. Fluoroquinolone administration within 8 h of ICU arrival (OR 0.16; 95% CI 0.03-0.96; p=0.035) was associated with a reduced mortality. CONCLUSIONS: SAPS II score higher than 46, duration of symptoms prior to ICU admission longer than 5 days and intubation were associated with increased mortality. Initiation of fluoroquinolone therapy within 8 h of ICU admission significantly reduced mortality.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Legionella pneumophila , Legionnaires' Disease/drug therapy , APACHE , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents/administration & dosage , Drug Therapy, Combination , Female , Fluoroquinolones , Humans , Intensive Care Units , Legionnaires' Disease/classification , Legionnaires' Disease/mortality , Macrolides , Male , Middle Aged , Prognosis , Retrospective Studies , Time Factors
19.
Intensive Care Med ; 26(9): 1232-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11089747

ABSTRACT

OBJECTIVE: To assess the use of procalcitonin (PCT) for the diagnosis of infection in a medical ICU. DESIGN: Prospective, observational study. PATIENTS: Seventy-seven infected patients and 24 patients with systemic inflammatory response syndrome (SIRS) due to other causes. Seventy-five patients could be classified into sepsis (n = 24), severe sepsis (n = 27) and septic shock (n = 24), and 20 SIRS patients remained free from infection during the study. Plasma PCT and C-reactive protein (CRP) levels were evaluated within 48 h of admission (day 0), at day 2 and day 4. RESULTS: As compared with SIRS, PCT and CRP levels at day 0 were higher in infected patients, regardless of the severity of sepsis (25.2 +/- 54.2 ng/ml vs 4.8 +/- 8.7 ng/ml; 159 +/- 92 mg/l vs 71 +/- 58 mg/l, respectively). At cut-off values of 2 ng/ml (PCT) and 100 mg/l (CRP), sensitivity and specificity were 65% and 70% (PCT), 74% and 74% (CRP). PCT and CRP levels were significantly more elevated in septic shock (38.5 +/- 59.1 ng/ml and 173 +/- 98 mg/l) than in SIRS (3.8 +/- 6.9 ng/ml and 70 +/- 48 mg/l), sepsis (1.3 +/- 2.7 ng/ml and 98 +/- 76 mg/l) and severe sepsis (9.1 +/- 18. 2 ng/ml and 145 +/- 70 mg/l) (all p = 0.005). CRP, but not PCT, levels were more elevated in severe sepsis than in SIRS (p<0.0001). Higher PCT levels in the patients with four dysfunctional organs and higher PCT and CRP levels in nonsurvivors may only reflect the marked inflammatory response to septic shock. CONCLUSION: In this study, PCT and CRP had poor sensitivity and specificity for the diagnosis of infection. PCT did not clearly discriminate SIRS from sepsis or severe sepsis.


Subject(s)
Calcitonin/blood , Glycoproteins/blood , Intensive Care Units , Protein Precursors/blood , Sepsis/blood , Analysis of Variance , Biomarkers/blood , C-Reactive Protein/analysis , Calcitonin Gene-Related Peptide , Chi-Square Distribution , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Sepsis/diagnosis , Severity of Illness Index , Statistics, Nonparametric
20.
Shock ; 13(2): 85-91, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10670837

ABSTRACT

Activation of the nuclear regulatory factor NF-kappaB occurs in the lungs of patients with the acute respiratory distress syndrome (ARDS) and may contribute to the increased expression of immunoregulatory cytokines and other proinflammatory mediators in this setting. Because of the important role that NF-kappaB activation appears to play in the development of acute lung injury, we examined cytoplasmic and nuclear NF-kapppaB counterregulatory mechanisms, involving IkappaB proteins, in alveolar macrophages obtained from 7 control patients without lung injury and 11 patients with established ARDS. Cytoplasmic levels of the NF-kappaB subunits p50, p65, and c-Rel were significantly decreased in alveolar macrophages from patients with ARDS, consistent with enhanced migration of liberated NF-kappaB dimers from the cytoplasm to the nucleus. Cytoplasmic and nuclear levels of IkappaBalpha were not significantly altered in alveolar macrophages from patients with established ARDS, compared with controls. In contrast, nuclear levels of Bcl-3 were significantly decreased in patients with ARDS compared with controls (P = 0.02). No IkappaBgamma, IkappaBbeta, or p105 proteins were detected in the cytoplasm of alveolar macrophages from control patients or patients with ARDS. The presence of activated NF-kappaB in alveolar macrophages from patients with established ARDS implies the presence of an ongoing stimulus for NF-kappaB activation. In this setting, appropriate counterregulatory mechanisms to normalize nuclear levels of NF-kappaB and to suppress NF-kappaB-mediated transcription, such as increased cytoplasmic and nuclear IkappaBalpha levels or decreased Bcl-3 levels, appeared to be induced. Nevertheless, even though counterregulatory mechanisms to NF-kappaB activation are activated in lung macrophages of patients with ARDS, NF-kappaB remains activated. These results suggest that fundamental abnormalities in transcriptional mechanisms involving NF-kappaB and important in the inflammatory response occur in the lungs of patients with ARDS.


Subject(s)
I-kappa B Proteins , Macrophages, Alveolar/metabolism , NF-kappa B/metabolism , Respiratory Distress Syndrome/metabolism , B-Cell Lymphoma 3 Protein , Bronchoalveolar Lavage , Cell Nucleus/metabolism , Cytoplasm/metabolism , DNA-Binding Proteins/metabolism , Female , Humans , Macrophages, Alveolar/immunology , Male , Middle Aged , NF-KappaB Inhibitor alpha , NF-kappa B p50 Subunit , Protein Precursors/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-rel/metabolism , Respiratory Distress Syndrome/immunology , Severity of Illness Index , Transcription Factor RelA , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...